Vitality Watch

Dossier pubmed observational 29-jun-2026
Human cohort, case-control, or epidemiological association

Mammalian aging involves genome-wide splicing degeneration leading to functional decline.

Key claim: Aging is marked by genome-wide deterioration of RNA splicing fidelity (splicing degeneration) that impairs protein reading frames and domains, rises with age, is alleviated by calorie restriction or rapamycin, and is linked to age-related changes in specific splicing factors.

Abstract

Alternative splicing exhibits significant changes during development and aging, affecting the composition and variance in the transcriptome. However, it is unclear whether and how age-associated splicing dysregulation leads to functional consequences. Here, an integrative analysis of transcriptome data across mouse and human tissues revealed that aging is characterized by systematic deterioration of the fidelity of RNA splicing, here termed splicing degeneration, a measure of functional alteration of reading frame and domain configuration of protein products. Genes with higher aging-associated splicing degeneration were more conserved and enriched for processes such as RNA metabolism and antigen presentation. By assessing alternative splicing events associated with functional deterioration, we quantified the degree of splicing degeneration. Its level increased with age but was alleviated following calorie restriction or rapamycin treatment, indicating that it can serve as a new molecular hallmark of aging. Mechanistically, through a comprehensive meta-data analysis, we discovered that splicing degeneration is associated with age-associated changes in specific splicing factors, which in turn showed a strong association with age-related transcriptome changes. Overall, our study demonstrates the intricate relationship between aging and genome-wide splicing degeneration, revealing a promising target for aging interventions acting to reverse splicing degeneration.

Why this matters

Splicing fidelity has been suspected as an aging axis but rarely quantified genome-wide across species; framing it as a hallmark that both tracks chronological age and responds to the two most robust longevity interventions (CR, rapamycin) situates the spliceosome as a downstream integrator of nutrient sensing rather than an independent lesion. If the age-CR-rapamycin signature holds, splicing-based readouts could join methylation and proteomic clocks as mechanism-linked biomarkers, though everything here is cross-sectional transcriptomics in mice and human tissues without an interventional human arm.

Source

Link

Briefing card

Mammalian aging involves genome-wide splicing degeneration leading to functional decline.
Stage: observational · pubmed · 29-jun-2026

Aging is marked by genome-wide deterioration of RNA splicing fidelity (splicing degeneration) that impairs protein reading frames and domains, rises with age, is alleviated by calorie restriction or rapamycin, and is linked to age-related changes in specific splicing factors.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.64898/2026.06.26.734787

build build 880 · 2bcef25 · 2026-11-18